The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial of dexamethasone mouthwash to prevent chemotherapy-induced oral mucositis in patients with breast cancer.
 
Sayaka Kuba
Honoraria - Chugai/Roche; Daiichi Sankyo/UCB Japan; Exact Sciences; Gilead Sciences
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; Pfizer
Research Funding - Pfizer/Seagen
Expert Testimony - Pfizer
 
Yasuhiro Hagiwara
Honoraria - Eisai (I); PDRadiopharma Inc. (I)
 
Nobuhiro Shibata
Honoraria - Bristol-Myers Squibb K.K.; Chugai Pharma; Daiichi Sankyo Co., Ltd.; Eisai; Kyowa Kirin Co., Ltd.; Lilly Japan; Merck; MSD K.K.; Nippon Kayaku; Pfizer
Consulting or Advisory Role - Chugai Pharma; Daiichi Sankyo Co., Ltd.; Kyowa Kirin Co., Ltd.
Research Funding - AstraZeneca Japan (Inst); Daiichi Sankyo Co., Ltd. (Inst); MSD K.K. (Inst)
 
Takafumi Sangai
Honoraria - AstraZeneca Japan; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Eisai; Exact Sciences; Gilead Sciences; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; PDRadiopharma; Pfizer
Research Funding - Chugai Pharma; Kyowa Kirin International
 
Ryoichi Matsunuma
No Relationships to Disclose
 
Uhi Toh
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; Pfizer
 
Kenichi Watanabe
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Kyowa Kirin; Nippon Kayaku; Pfizer
 
Takayuki Iwamoto
No Relationships to Disclose
 
Kosho Yamanouchi
Speakers' Bureau - AstraZeneca; Chugai Pharma; MSD
 
Michiko Harao
No Relationships to Disclose
 
Miki Yamaguchi
Honoraria - AstraZeneca Japan; Chugai/Roche; Daiichi Sankyo; Kyowa Kirin; Lilly Japan
 
Masahiko Suzuki
No Relationships to Disclose
 
Shigeto Maeda
Honoraria - Daiichi Sankyo/UCB Japan; Kyowa Hakko Kirin; Lilly Japan
 
Noriko Maeda
No Relationships to Disclose
 
Akiko Ebata
No Relationships to Disclose
 
Nobutaka Iwakuma
No Relationships to Disclose
 
Sakiko Soutome
No Relationships to Disclose
 
Takeshi Yamaguchi
No Relationships to Disclose
 
Yuichiro Kikawa
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Gilead Sciences; Lilly Japan; MSD; Pfizer; Taiho Pharmaceutical
 
Hirofumi Mukai
Honoraria - Daiichi Sankyo; Taiho Pharmaceutical; Takeda